back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-09-25 09:53 Tx date 2025-09-25 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,541 vol |
12,313 | |
| Filed 2025-08-11 11:41 Tx date 2025-08-08 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$195,481
+4,499 vol $43.45 each |
8,299 | |
| Filed 2025-06-24 09:54 Tx date 2025-06-24 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,589 vol |
10,772 | |
| Filed 2025-05-15 15:29 Tx date 2025-05-15 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+2,014 vol |
9,183 | |
| Filed 2024-12-23 12:32 Tx date 2024-12-23 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,764 vol |
7,169 | |
| Filed 2024-11-27 16:27 Tx date 2024-11-22 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$108,262
+3,800 vol $28.49 each |
3,800 | |
| Filed 2024-11-27 16:26 Tx date 2024-02-14 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-09-25 09:13 Tx date 2024-09-24 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+2,428 vol |
5,405 | |
| Filed 2024-06-25 17:29 Tx date 2024-06-25 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+2,090 vol |
2,977 | |
| Filed 2024-04-02 10:10 Tx date 2024-03-31 |
$MDA
MDA Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+887 vol |
887 | |
| Filed 2024-04-02 10:09 Tx date 2024-02-14 |
$MDA
MDA Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-13 16:04 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,267
+13,334 vol $1.07 each |
333,334 | |
| Filed 2024-01-13 16:03 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-14,267.38
-13,334 vol $1.07 each |
1,666 | |
| Filed 2023-11-18 15:20 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,733
+1,667 vol $1.04 each |
320,000 | |
| Filed 2023-11-18 15:19 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,733.68
-1,667 vol $1.04 each |
15,000 | |
| Filed 2023-09-15 18:24 Tx date 2023-09-12 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
40,000 | |
| Filed 2023-01-14 15:54 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,866
+13,333 vol $0.59 each |
318,333 | |
| Filed 2023-01-14 15:53 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-7,866.47
-13,333 vol $0.59 each |
16,667 | |
| Filed 2022-12-01 22:19 Tx date 2022-11-28 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,560
+5,334 vol $0.48 each |
305,000 | |
| Filed 2022-12-01 22:18 Tx date 2022-11-28 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-2,560.32
-5,334 vol $0.48 each |
30,000 |